Acutus Medical, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 16.36 million compared to USD 17.26 million a year ago. Net loss was USD 39.62 million compared to USD 117.68 million a year ago.

Basic loss per share from continuing operations was USD 1.4 compared to USD 4.11 a year ago. Diluted loss per share from continuing operations was USD 1.4 compared to USD 4.11 a year ago.